ReviewFrontiers in pharmacology2025
CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects.
Han Han et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it